The Prognostic Value of the Circulating Tumor Cell-Based Four mRNA Scoring System: A New Non-Invasive Setting for the Management of Bladder Cancer

The Prognostic Value of the Circulating Tumor Cell-Based Four mRNA Scoring System: A New Non-Invasive Setting for the Management of Bladder Cancer

Bladder cancer (BC) is one of the most expensive lifetime cancers to treat because of the high recurrence rate, repeated surgeries, and long-term cystoscopy monitoring and treatment. The lack of an accurate classification system predicting the risk of recurrence or progression leads to the search fo...

Full description

Bibliographic Details
Main Authors: Consuelo Amantini, Federica Maggi, Jacopo Adolfo Rossi de Vermandois, Marilena Gubbiotti, Antonella Giannantoni, Ettore Mearini, Massimo Nabissi, Daniele Tomassoni, Giorgio Santoni, Maria Beatrice Morelli
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Cancers
Subjects:
circulating tumor cells
bladder cancer
recurrence
mRNA scoring system
TRPM4
Online Access:https://www.mdpi.com/2072-6694/14/13/3118

Internet

https://www.mdpi.com/2072-6694/14/13/3118

Similar Items